secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cartesian Therapeutics, Inc. (RNAC)
CIK:        0001453687
Form:       8-K/A
Filed at:   2024-01-23T23:59:59+00:00
Accession:  0001140361-24-003407
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cartesian Therapeutics files financials for acquired Old Cartesian and pro forma
--------------------------------------------------------------------------------

- Old Cartesian net loss $6.5M in 2022, vs $3.6M in 2021; grant revenue $1.4M in 2022.
- Old Cartesian cash $12.0M at Dec 31, 2022; accumulated deficit $26.1M.
- Unaudited pro forma financials reflect combined entity post-merger closed Nov 13, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453687/000114036124003407/0001140361-24-003407-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453687/000114036124003407/ny20014884x4_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-003407

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer